These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18704335)

  • 1. In Vitro/in vivo relationship of gabapentin from a sustained-release tablet formulation: a pharmacokinetic study in the beagle dog.
    Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Han SB; Lee DS; Park ES
    Arch Pharm Res; 2008 Jul; 31(7):911-7. PubMed ID: 18704335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food.
    Chen C; Cowles VE; Hou E
    J Clin Pharmacol; 2011 Mar; 51(3):346-58. PubMed ID: 20484610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic of gabapentin 600 mg tablet in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N; Khemsri W; Prompila N; Sayankuldilok N; Punyasang W
    J Med Assoc Thai; 2012 Apr; 95(4):583-9. PubMed ID: 22612015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of gabapentin in horses.
    Dirikolu L; Dafalla A; Ely KJ; Connerly AL; Jones CN; ElkHoly H; Lehner AF; Thompson K; Tobin T
    J Vet Pharmacol Ther; 2008 Apr; 31(2):175-7. PubMed ID: 18307511
    [No Abstract]   [Full Text] [Related]  

  • 6. Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect.
    Sonvico F; Conti C; Colombo G; Buttini F; Colombo P; Bettini R; Barchielli M; Leoni B; Loprete L; Rossi A
    J Control Release; 2017 Sep; 262():296-304. PubMed ID: 28774840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Antonijoan R; García-Gea C; Gich I; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):59-63. PubMed ID: 16572918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures.
    Tallian KB; Nahata MC; Lo W; Tsao CY
    J Clin Pharm Ther; 2004 Dec; 29(6):511-5. PubMed ID: 15584938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application.
    Yagi T; Naito T; Mino Y; Takashina Y; Umemura K; Kawakami J
    J Clin Pharm Ther; 2012 Feb; 37(1):89-94. PubMed ID: 21276028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intestinal absorption mechanism of gabapentin makes it appropriate for gastroretentive delivery.
    Chen C; Cowles VE; Sweeney M
    Curr Clin Pharmacol; 2013 Feb; 8(1):67-72. PubMed ID: 22946876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioequivalence evaluation of two gabapentin preparations after a single oral dose in healthy Korean volunteers.
    Cho HY; Kang HA; Lee YB
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):386-92. PubMed ID: 16961169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oral gabapentin in greyhound dogs.
    Kukanich B; Cohen RL
    Vet J; 2011 Jan; 187(1):133-5. PubMed ID: 19854080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
    Rao MR; Bhingole RC
    Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of gabapentin in cats.
    Siao KT; Pypendop BH; Ilkiw JE
    Am J Vet Res; 2010 Jul; 71(7):817-21. PubMed ID: 20594085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin to pregabalin therapy transition: a pharmacokinetic simulation.
    Bockbrader HN; Budhwani MN; Wesche DL
    Am J Ther; 2013 Jan; 20(1):32-6. PubMed ID: 23018586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LC-MS/MS method for quantification and pharmacokinetic study of gabapentin in human plasma].
    Xiong ZL; Yu J; He JF; Qin F; Li FM
    Yao Xue Xue Bao; 2011 Oct; 46(10):1246-50. PubMed ID: 22242459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHARMACOKINETIC PROPERTIES OF A SINGLE ADMINISTRATION OF ORAL GABAPENTIN IN THE GREAT HORNED OWL (BUBO VIRGINIANUS).
    Yaw TJ; Zaffarano BA; Gall A; Olds JE; Wulf L; Papastavros E; Coetzee JF
    J Zoo Wildl Med; 2015 Sep; 46(3):547-52. PubMed ID: 26352959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interchangeability of gabapentin generic formulations in the Netherlands: a comparative bioavailability study.
    Yu Y; Teerenstra S; Vanmolkot F; Neef C; Burger D; Maliepaard M
    Clin Pharmacol Ther; 2013 Oct; 94(4):519-24. PubMed ID: 23708746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of MDR1 G2677T/A polymorphism on pharmacokinetics of gabapentin in healthy Korean subjects.
    Kang HA; Cho HY; Lee YB
    Arch Pharm Res; 2007 Jan; 30(1):96-101. PubMed ID: 17328248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview.
    Argoff CE; Chen C; Cowles VE
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1147-60. PubMed ID: 22809245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.